Contributory conditions for unexpected COVID-19 cases and nosocomial COVID-19 infection cases identified from systematic investigation in a French University Hospital.


Journal

Infectious diseases now
ISSN: 2666-9919
Titre abrégé: Infect Dis Now
Pays: France
ID NLM: 101775152

Informations de publication

Date de publication:
Apr 2023
Historique:
received: 30 08 2022
revised: 30 12 2022
accepted: 13 01 2023
medline: 8 5 2023
pubmed: 27 1 2023
entrez: 26 1 2023
Statut: ppublish

Résumé

Nosocomial case (NC) of COVID-19 infections is a challenge for hospitals. We report the results of a seven-month prospective cohort study investigating COVID-19 patients to assess unexpected cases (UC) (no COVID-19 precautionary measure application since admission) and NC. Investigation by an infection control team of 844 patients with COVID-19 infection hospitalized for more than 24 hours (cases). A total of 301 UC were identified (31% after contact tracing) with a total of 129 contact patients, and 27 secondary cases for 59 of them. In geriatric wards, 50% of cases were UC. NC represented 18% of cases (37% in geriatric wards), mainly identified after contact tracing of wandering cases. A rapid infection control response is essential to contain nosocomial transmission, along with detailed contact tracing and screening policy. Dealing with wandering elderly patients remain challenging for HCWs.

Identifiants

pubmed: 36702305
pii: S2666-9919(23)00010-6
doi: 10.1016/j.idnow.2023.104648
pmc: PMC9869609
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

104648

Informations de copyright

Copyright © 2023 Elsevier Masson SAS. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Y Carré (Y)

University Hospital of Bordeaux, Infection Prevention and Control Unit, F-33000 Bordeaux, France. Electronic address: yolene.carre@chu-bordeaux.fr.

M Coppry (M)

University Hospital of Bordeaux, Infection Prevention and Control Unit, F-33000 Bordeaux, France; University Hospital of Bordeaux, Inserm, Bordeaux Population Health Research Center, F-33000 Bordeaux, France.

C Bataille (C)

University Hospital of Bordeaux, Infection Prevention and Control Unit, F-33000 Bordeaux, France.

L Vivier (L)

University Hospital of Bordeaux, Infection Prevention and Control Unit, F-33000 Bordeaux, France.

A Lasheras-Bauduin (A)

University Hospital of Bordeaux, Infection Prevention and Control Unit, F-33000 Bordeaux, France.

A-M Rogues (AM)

University Hospital of Bordeaux, Infection Prevention and Control Unit, F-33000 Bordeaux, France; University Hospital of Bordeaux, Inserm, Bordeaux Population Health Research Center, F-33000 Bordeaux, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH